Corcept Therapeutics (CORT) Cash from Investing Activities Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.60% |
| Dec 31, 2025 | -25.03% |
| Sep 30, 2025 | 17.38% |
| Jun 30, 2025 | 23.01% |
| Mar 31, 2025 | -16.66% |
| Dec 31, 2024 | -0.75% |
| Sep 30, 2024 | 4.11% |
| Jun 30, 2024 | -120.45% |
| Mar 31, 2024 | -89.69% |
| Dec 31, 2023 | 63.63% |
| Sep 30, 2023 | -26.74% |
| Jun 30, 2023 | -2.58% |
| Mar 31, 2023 | 51.76% |
| Dec 31, 2022 | 8.88% |
| Sep 30, 2022 | 16.28% |
| Jun 30, 2022 | -22.83% |
| Mar 31, 2022 | -21.07% |
| Dec 31, 2021 | 351.44% |
| Sep 30, 2021 | -210.09% |
| Jun 30, 2021 | 412.53% |
| Mar 31, 2021 | -172.14% |
| Dec 31, 2020 | 266.36% |
| Mar 31, 2020 | 257.31% |
| Sep 30, 2019 | -408.35% |
| Jun 30, 2019 | -88.95% |
| Mar 31, 2019 | -27.25% |
| Dec 31, 2018 | -113.08% |
| Sep 30, 2018 | -248.69% |
| Jun 30, 2018 | -455.78% |
| Mar 31, 2018 | -352.88% |
| Dec 31, 2017 | -242.78% |
| Sep 30, 2017 | -195.15% |
| Jun 30, 2017 | -237.77% |
| Mar 31, 2017 | -388.20% |